S2-E45.3 - Discussing the EASL Guidelines and the Path to A Non-Invasive Testing Future with Donna Cryer

Send us a text Global Liver Institute President and CEO Donna Cryer joins Roger Green to discuss why recent EASL guidelines around use of non-invasive tests (NITs) in Fatty Liver diagnosis and disease tracking is such an important step for patients and treaters alike. To Global Liver Institute President and CEO Donna Cryer, the recent EASL Guidelines on use of non-invasive testing (NITs) represent a major breakthrough in GLI's ongoing "Beyond the Biopsy" campaign. In this one-on-one int...